chr6-123512344-A-AT
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_006073.4(TRDN):c.568_569insA(p.Ile190AsnfsTer2) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
TRDN
NM_006073.4 frameshift
NM_006073.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0100
Genes affected
TRDN (HGNC:12261): (triadin) This gene encodes an integral membrane protein found in skeletal and cardiac muscle. The encoded protein plays a role in skeletal muscle excitation-contraction coupling as part of the calcium release complex and is required for normal skeletal muscle strength. This protein indirectly links triads and microtubules in skeletal muscle. Mutations in this gene are associated with cardiac arrythmia syndrome and some variants in this gene may be associated with sudden cardiac death. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-123512344-A-AT is Pathogenic according to our data. Variant chr6-123512344-A-AT is described in ClinVar as [Likely_pathogenic]. Clinvar id is 225497.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRDN | NM_006073.4 | c.568_569insA | p.Ile190AsnfsTer2 | frameshift_variant | 7/41 | ENST00000334268.9 | NP_006064.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRDN | ENST00000334268.9 | c.568_569insA | p.Ile190AsnfsTer2 | frameshift_variant | 7/41 | 1 | NM_006073.4 | ENSP00000333984 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1353066Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 672998
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1353066
Hom.:
Cov.:
26
AF XY:
AC XY:
0
AN XY:
672998
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, no assertion criteria provided | provider interpretation | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Feb 02, 2018 | Variant TRDN, Exon 7, p.Ile190Asnfs*2 (c.568dupA) NM_001251987.1 chr6-123833490--T SCICD classification Likely pathogenic (for recessive disease) We do feel it is suitable for assessing risk in healthy relatives ("predictive genetic testing"). The rationale for this assessment is: type of variant in this gene likely to be pathogenic, sufficiently rare. Gene-level evidence TRDN variants are newly recognized as a cause of autosomal recessive arrhythmic syndromes resembling CPVT and long QT syndrome. Several of the reported pathogenic variants are nonsense, frameshift, or splice. As far as we are aware phenotype in heterozygotes has not been reported. Case data summary Per lab report and my searches, variant has not been reported with disease. Population Data There is no variation at this genomic position in gnomAD. Metrics indicate adequate coverage. - |
Catecholaminergic polymorphic ventricular tachycardia 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2020 | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in TRDN are known to be pathogenic (PMID: 25922419). This variant has not been reported in the literature in individuals with TRDN-related disease. ClinVar contains an entry for this variant (Variation ID: 225497). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ile190Asnfs*2) in the TRDN gene. It is expected to result in an absent or disrupted protein product. - |
Catecholaminergic polymorphic ventricular tachycardia 5 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at